Your browser doesn't support javascript.
loading
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.
Ang, Yuen-Siang; Bruder, Gerard E; Keilp, John G; Rutherford, Ashleigh; Alschuler, Daniel M; Pechtel, Pia; Webb, Christian A; Carmody, Thomas; Fava, Maurizio; Cusin, Cristina; McGrath, Patrick J; Weissman, Myrna; Parsey, Ramin; Oquendo, Maria A; McInnis, Melvin G; Cooper, Crystal M; Deldin, Patricia; Trivedi, Madhukar H; Pizzagalli, Diego A.
Afiliación
  • Ang YS; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Bruder GE; Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts, USA.
  • Keilp JG; Department of Psychiatry, New York State Psychiatric Institute and Columbia University Vagelos College of Physicians and Surgeons, New York, USA.
  • Rutherford A; Department of Psychiatry, New York State Psychiatric Institute and Columbia University Vagelos College of Physicians and Surgeons, New York, USA.
  • Alschuler DM; Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts, USA.
  • Pechtel P; Department of Psychiatry, New York State Psychiatric Institute and Columbia University Vagelos College of Physicians and Surgeons, New York, USA.
  • Webb CA; Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts, USA.
  • Carmody T; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Fava M; Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts, USA.
  • Cusin C; Department of Psychiatry, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
  • McGrath PJ; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Weissman M; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Parsey R; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Oquendo MA; Department of Psychiatry, New York State Psychiatric Institute and Columbia University Vagelos College of Physicians and Surgeons, New York, USA.
  • McInnis MG; Department of Psychiatry, New York State Psychiatric Institute and Columbia University Vagelos College of Physicians and Surgeons, New York, USA.
  • Cooper CM; Department of Psychiatry, Stony Brook University, Stony Brook, New York, USA.
  • Deldin P; Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Trivedi MH; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
  • Pizzagalli DA; Department of Psychiatry, University of Texas, Southwestern Medical Center, Dallas, Texas, USA.
Psychol Med ; 52(13): 2441-2449, 2022 10.
Article en En | MEDLINE | ID: mdl-33213541
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sertralina / Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sertralina / Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos